The Faculty of Life Sciences & Medicine at King's has launched a new master's programme in Biotechnology and Computational ...

While responding to a query raised regarding the availability of medical seats under the All India Quota, the Union Minister ...

Trust is often a major barrier to companies integrating AI tools. Learn how better data governance can improve confidence.

Germany’s Formycon and Jordan-based MS Pharma have entered into an exclusive licensing and supply agreement for the commercialization of FYB206, Formycon’s biosimilar candidate to the blockbuster drug ...

About NKGen Biotech, Inc. NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is ...

The Union Health Ministry has informed the Parliament on Tuesday that the doctor-population ratio in the country is 1:811, ...

Biotechnology is not merely a scientific discipline but a form of strategic “knowledge infrastructure” essential for health, ...

BioTouch, a health care logistics company based in West Haven, Connecticut, will invest $12.5 million to expand its two facilities in Columbus, Georgia. During a press conference on Dec. 4, 2025 ...

Quinlan who has resigned for health reasons after taking medical leave in September 2025PHILADELPHIA, Dec. 01, 2025 (GLOBE ...

As a town’s water supply crisis enters its fifth day, KentOnline has gone in search of the company boss responsible for ...

Lisaftoclax monotherapy demonstrated significant and durable clinical efficacy and a manageable safety profile in patients with heavily pretreated BTK-refractory R/R CLL/SLL, underscoring its utility ...

NKGen Korea, formerly NKMax Co., recently completed a shareholder-approved name change on November 21, 2025. On this date, NKGen Korea also ...